Navigation Links
TransMessenger Transfection Reagent Handbook

web site contains siRNA transfection protocols and the most up-to-date information and literature on QIAGEN reagents for RNAi. Visit the Transfection Tools site for answers to your RNAi questions www.qiagen.com/transfectiontools/.

Optimizing siRNA Transfection

To achieve the best results in siRNA transfection we recommend optimizing the following parameters.

Amount of siRNA and Enhancer R
The amount of siRNA used is a critical factor for efficient transfection and gene silencing. The recommended starting amount for transfection of siRNA in 24-well plates is 0.8 g. A pipetting scheme for optimizing the transfection of siRNA in adherent cells in a 24-well format is provided in Table 4 on page 16. Always use a 1:2 ratio of nucleic acid (g) to Enhancer R (l).

Ratio of TransMessenger Transfection Reagent to siRNA
The ratio of TransMessenger Transfection Reagent to siRNA should be optimized for every new cell type and siRNA combination used. As a starting point for optimization we recommend using an siRNA to TransMessenger Transfection Reagent ratio (g:l) of 1:5 when using 24-well plates. To optimize siRNA transfection in 24-well format, prepare separate transfection mixtures using:
The starting point siRNA and TransMessenger Reagent quantities that are given in the protocol on page 16
Half the listed quantities and ratios
Double the listed ratios and quantities.

Cell density at transfection
The optimal confluency for transfection of adherent cells with siRNA is 5080%. The optimal confluency should be determined for every new cell type
'"/>

Source:


Page: All 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related biology technology :

1. TransMessenger Transfection Reagent
2. Efficient DNA transfection of primary CNS neurons using TransMessenger Transfection Reagent
3. TransMessenger Transfection Reagent
4. Efficient RNAi-mediated gene silencing in neuronal cells using QIAGEN siRNA and TransMessenger Transfection Reagent*
5. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
6. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
7. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
8. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
9. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
10. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
11. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: TransMessenger Transfection Reagent Handbook

(Date:2/27/2015)... 27, 2015 Immunovaccine Inc. (“Immunovaccine” or ... a fraudulent press release disseminated this morning by PR ... Immunovaccine. This press release states that Immunovaccine has entered ... The press release did not originate from Immunovaccine and ... the press release. Please note that all official ...
(Date:2/27/2015)... Scotia (PRWEB) February 27, 2015 ... vaccine and immunotherapy company, today announced that the ... application for Fast Track designation and Phase I ... in conjunction with the mutual co-development agreement signed ... obtained Fast Track designation for the DPX-Survivac. , ...
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/26/2015)... 2015  23andMe, the leading personal genetics company, today ... Privacy Officer and Corporate Counsel. Black brings a strong ... well as health care regulations. As a member of ... for reviewing, updating and enhancing the company,s privacy and ... She joined the company January 5, 2015 and reports ...
Breaking Biology Technology:Immunovaccine Disclaims Hoax Press Release 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 2Immunovaccine Inc. (TSX: IMV) receives Fast Track and Phase I trial approval for Ebola and Anthrax vaccine programs, signs co-development agreement with Gilead Sciences 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 623andMe Appoints Kate Black as Privacy Officer and Corporate Counsel 2
... 18 Jennifer Brownstein, Art Director at ... 2009 Rising Star by the Healthcare Businesswomen,s ... professionals in various sectors of the healthcare ... medical education, and market research. Nominated by ...
... /PRNewswire-Asia/ -- Obio Pharmaceutical Holdings Ltd,("Obio"/ "the ... the,international pharmaceutical arena. With a strong product ... international investors including Yangtze,Ventures Limited (New World ... Properties,Limited, Yu Hwa Chinese Products Group, YangtzeKiang ...
... a private,specialty pharmaceutical company, announced that the U.S. Food ... July 15, 2009 for,completion of its review of the ... Zogenix is seeking marketing approval,of Sumavel DosePro for the ... the acute treatment of cluster headache episodes. , ...
Cached Biology Technology:Jennifer Brownstein, of CONNEXION Healthcare, Honored as 'Rising Star' by Healthcare Businesswomen's Association 2Obio Pharmaceutical Announces Product Growth Strategy 2Obio Pharmaceutical Announces Product Growth Strategy 3Zogenix Reports FDA Provides New PDUFA Date for Sumavel(TM) DosePro(TM) 2
(Date:2/13/2015)... 2015 ACT Genomics Co., Ltd., a ... transform cancer genomic information into precision diagnosis and ... raised US$ 8 million in the its first private ... Taipei, Taiwan , ACT Genomics has developed ... aim to implement next generation sequencing (NGS) and ...
(Date:2/12/2015)... Conn. , Feb. 12, 2015 NXT-ID, ... or the "Company"), a biometric authentication company focused on ... has filed provisional patent 62/113114 for DISTRIBUTED ... DEVICES. The patent further establishes NXT-ID,s position ... its intellectual property portfolio the ability for multiple devices ...
(Date:2/10/2015)... Mass., Feb. 10, 2015  Alere Inc. (NYSE: ... its financial results for the quarter ended December ... Officer and President of Alere said, "We made ... Alere as the global leader in rapid diagnostics ... the Alere Health divestiture in early January enabled ...
Breaking Biology News(10 mins):ACT Genomics Raises $8 Million in its First Private Funding Round 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3Alere Inc. Announces Fourth Quarter 2014 Results 2Alere Inc. Announces Fourth Quarter 2014 Results 3Alere Inc. Announces Fourth Quarter 2014 Results 4Alere Inc. Announces Fourth Quarter 2014 Results 5Alere Inc. Announces Fourth Quarter 2014 Results 6Alere Inc. Announces Fourth Quarter 2014 Results 7Alere Inc. Announces Fourth Quarter 2014 Results 8Alere Inc. Announces Fourth Quarter 2014 Results 9Alere Inc. Announces Fourth Quarter 2014 Results 10Alere Inc. Announces Fourth Quarter 2014 Results 11Alere Inc. Announces Fourth Quarter 2014 Results 12Alere Inc. Announces Fourth Quarter 2014 Results 13Alere Inc. Announces Fourth Quarter 2014 Results 14Alere Inc. Announces Fourth Quarter 2014 Results 15Alere Inc. Announces Fourth Quarter 2014 Results 16Alere Inc. Announces Fourth Quarter 2014 Results 17Alere Inc. Announces Fourth Quarter 2014 Results 18Alere Inc. Announces Fourth Quarter 2014 Results 19Alere Inc. Announces Fourth Quarter 2014 Results 20Alere Inc. Announces Fourth Quarter 2014 Results 21Alere Inc. Announces Fourth Quarter 2014 Results 22Alere Inc. Announces Fourth Quarter 2014 Results 23Alere Inc. Announces Fourth Quarter 2014 Results 24Alere Inc. Announces Fourth Quarter 2014 Results 25Alere Inc. Announces Fourth Quarter 2014 Results 26Alere Inc. Announces Fourth Quarter 2014 Results 27Alere Inc. Announces Fourth Quarter 2014 Results 28Alere Inc. Announces Fourth Quarter 2014 Results 29Alere Inc. Announces Fourth Quarter 2014 Results 30Alere Inc. Announces Fourth Quarter 2014 Results 31Alere Inc. Announces Fourth Quarter 2014 Results 32Alere Inc. Announces Fourth Quarter 2014 Results 33
... dead organisms could serve as a relatively fast, simple and ... University of Chicago,s Susan Kidwell explains how measuring the degree ... in the Oct. 26 early online edition of the Proceedings ... in many different ways, but the effects of our actions ...
... has been brought back to life in stunning 3D ... In a paper published in the latest issue of ... Ghent University in Belgium report on the use of ... (VHR-CT) to digitally dissect tiny fossils and reveal the ...
... latest American Chemical Society (ACS) News Service Weekly,press ... journals and Chemical & Engineering News. With more ... society. Please,cite the individual journal, or the American ... ARTICLE #1 FOR IMMEDIATE RELEASE , , "Microplastics" ...
Cached Biology News:Dead clams tell many tales 2Dead clams tell many tales 3Dead clams tell many tales 4Scientist brings 50 million year old spider 'back to life' 2American Chemical Society's Weekly PressPac -- Oct. 24, 2007 2American Chemical Society's Weekly PressPac -- Oct. 24, 2007 3American Chemical Society's Weekly PressPac -- Oct. 24, 2007 4American Chemical Society's Weekly PressPac -- Oct. 24, 2007 5American Chemical Society's Weekly PressPac -- Oct. 24, 2007 6American Chemical Society's Weekly PressPac -- Oct. 24, 2007 7American Chemical Society's Weekly PressPac -- Oct. 24, 2007 8
...
... Staining Kit, Protein, 1. Based on ... (1), the kit gives essentially colorless ... Staining Kit, Protein provides convenient, reproducible ... polyacrylamide gels in less than two ...
Mouse monoclonal [IFR0104] to Salmonella enteriditis ( Abpromise for all tested applications)....
Cyno macaque plasma and serum - various quantities available...
Biology Products: